Open access peer-reviewed chapter

Chronic Inflammation and S100A12/ Receptor for Advanced Glycation Endproducts Axis: A Novel Risk Factor for Cardiovascular Disease in Patients with Chronic Kidney Disease?

By Yasukiyo Mori, Yayoi Shiotsu, Eiko Matsuoka, Hiroshi Kado, Ryo Ishida and Hiroaki Matsubara

Submitted: December 1st 2010Reviewed: May 17th 2011Published: November 14th 2011

DOI: 10.5772/24020

Downloaded: 1354

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Yasukiyo Mori, Yayoi Shiotsu, Eiko Matsuoka, Hiroshi Kado, Ryo Ishida and Hiroaki Matsubara (November 14th 2011). Chronic Inflammation and S100A12/ Receptor for Advanced Glycation Endproducts Axis: A Novel Risk Factor for Cardiovascular Disease in Patients with Chronic Kidney Disease?, Hemodialysis - Different Aspects, Maria Goretti Penido, IntechOpen, DOI: 10.5772/24020. Available from:

chapter statistics

1354total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Choice of Renal Replacement Therapy and Role of Haemodialysis in the Intensive Care Unit

By Marlies Ostermann

Related Book

First chapter

Bedside Linear Regression Equations to Estimate Equilibrated Blood Urea

By Elmer A. Fernández, Mónica Balzarini and Rodolfo Valtuille

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us